During the past decade, Medical Department III, Clinical Center Hanau conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Medical Department III, Clinical Center Hanau" are "Acute Myeloid Leukemia" (1 trials) and "Leukemia, Myeloid, Acute" (1 trials). Many other conditions were trialed in "Medical Department III, Clinical Center Hanau" in a lesser frequency.

Most popular intervention types in "Medical Department III, Clinical Center Hanau" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cytarabine" (2 trials), "All-trans retinoic acid" (1 trials), "All-trans-Retinoid Acid" (1 trials), "Etoposide" (1 trials) and "Gemtuzumab Ozogamicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical Department III, Clinical Center Hanau" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Medical Department III, Clinical Center Hanau". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Medical Department III, Clinical Center Hanau, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medical Department III, Clinical Center Hanau, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".